| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 13, 2024 | Buy | $7.29 | 1,010 | 7,363 | 15,503 | Mar 14, 2024, 08:54 PM | |
| APRE | Aprea Therapeutics, Inc. | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Feb 27, 2023 | Option Exercise | $5.25 | 1,000 | 5,250 | 14,493 | Feb 27, 2023, 06:37 PM | |
| WINT | WINDTREE THERAPEUTICS INC /DE/ | Hamill John P. | SVP & CFO | Jul 26, 2022 | Buy | $0.37 | 3,000 | 1,100 | 72,800 | Jul 26, 2022, 04:38 PM | |
| WINT | WINDTREE THERAPEUTICS INC /DE/ | Hamill John P. | SVP & CFO | Apr 16, 2021 | Buy | $2.07 | 1,000 | 2,067 | 3,500 | Apr 19, 2021, 07:49 AM | |
| WINT | WINDTREE THERAPEUTICS INC /DE/ | Hamill John P. | SVP & CFO | Mar 25, 2021 | Buy | $3.25 | 1,500 | 4,875 | 2,500 | Mar 25, 2021, 04:44 PM | |
| WINT | WINDTREE THERAPEUTICS INC /DE/ | Hamill John P. | SVP & CFO | Oct 07, 2020 | Buy | $5.27 | 1,000 | 5,270 | 1,000 | Oct 09, 2020, 08:06 AM | |
| TRVN | TREVENA INC | Hamill John P. | VP Fin,Princ Fin&Acct Officer | Jun 03, 2019 | Option Exercise | $1.17 | 5,516 | 6,454 | 82,234 | Jun 04, 2019, 04:52 PM | |
| TRVN | TREVENA INC | Hamill John P. | VP Fin,Princ Fin&Acct Officer | May 31, 2019 | Buy | $1.16 | 7,500 | 8,700 | 87,750 | Jun 04, 2019, 04:52 PM |
Menu